Pulmatrix, Inc. (PULM) stock
PULMNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.33+0.04 (+3.10%)
Close on Nov 16, 2026Market cap $4.86MP/E –Yield –
Pulmatrix operating margin
Operating margin is operating income as a percentage of revenue.
Pulmatrix's operating margin for the twelve months ending Dec 31, 2024 was -125.1%. For fiscal 2024 it was -125.1%, against -202.0% the year before. The highest annual figure on record is -78.1% in fiscal 2020.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | -125.1% | +76.9 |
| FY2023 | Dec 31, 2023 | -202.0% | +110.1 |
| FY2022 | Dec 31, 2022 | -312.1% | +78.1 |
| FY2021 | Dec 31, 2021 | -390.2% | −312.1 |
| FY2020 | Dec 31, 2020 | -78.1% | +183.5 |
| FY2019 | Dec 31, 2019 | -261.6% | +13071.7 |
| FY2018 | Dec 31, 2018 | -13333.3% | −8116.9 |
| FY2017 | Dec 31, 2017 | -5216.4% | −2238.5 |
| FY2016 | Dec 31, 2016 | -2978.0% | −1061.4 |
| FY2015 | Dec 31, 2015 | -1916.6% | +661.8 |
| FY2014 | Dec 31, 2014 | -2578.4% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2024 | Dec 31, 2024 | -65066.7% | −64965.6 |
| Q3 FY2024 | Sep 30, 2024 | -726.0% | −501.3 |
| Q2 FY2024 | Jun 30, 2024 | -380.2% | −163.8 |
| Q1 FY2024 | Mar 31, 2024 | 12.7% | +318.6 |
| Q4 FY2023 | Dec 31, 2023 | -101.0% | +152.2 |
| Q3 FY2023 | Sep 30, 2023 | -224.7% | +47.7 |
| Q2 FY2023 | Jun 30, 2023 | -216.4% | +126.1 |
| Q1 FY2023 | Mar 31, 2023 | -305.9% | +122.0 |
| Q4 FY2022 | Dec 31, 2022 | -253.2% | +633.4 |
| Q3 FY2022 | Sep 30, 2022 | -272.4% | +493.7 |
| Q2 FY2022 | Jun 30, 2022 | -342.5% | −171.8 |
| Q1 FY2022 | Mar 31, 2022 | -427.8% | −134.0 |
| Q4 FY2021 | Dec 31, 2021 | -886.6% | −752.9 |
| Q3 FY2021 | Sep 30, 2021 | -766.1% | −736.9 |
| Q2 FY2021 | Jun 30, 2021 | -170.8% | −137.2 |
| Q1 FY2021 | Mar 31, 2021 | -293.9% | −122.4 |
| Q4 FY2020 | Dec 31, 2020 | -133.7% | +110.3 |
| Q3 FY2020 | Sep 30, 2020 | -29.2% | +232.2 |
| Q2 FY2020 | Jun 30, 2020 | -33.5% | +131.4 |
| Q1 FY2020 | Mar 31, 2020 | -171.5% | +3171.0 |
| Q4 FY2019 | Dec 31, 2019 | -244.0% | +3098.4 |
| Q3 FY2019 | Sep 30, 2019 | -261.5% | +1023.3 |
| Q2 FY2019 | Jun 30, 2019 | -164.9% | +6209.4 |
| Q4 FY2018 | Dec 31, 2018 | -3342.5% | – |
| Q1 FY2018 | Mar 31, 2018 | -3342.5% | – |
| Q3 FY2017 | Sep 30, 2017 | -1284.8% | – |
| Q4 FY2016 | Dec 31, 2016 | -6374.4% | – |
See a number that looks wrong?